FFCP PHASE1:Mm9::chr12:57390214..57390221,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=50|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:57390214..57390221,+|id=chr12:57390214..57390221,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000084,5.67e-17,11;CL:0000827,5.67e-17,11;CL:0000838,1.13e-15,12;CL:0000542,1.42e-14,13;CL:0000051,1.42e-14,13;CL:0000738,1.86e-11,17;CL:0002087,1.86e-11,17;CL:0002031,3.41e-08,25|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002048!4.27e-16!14;UBERON:0000117!4.27e-16!14;UBERON:0000171!4.27e-16!14;UBERON:0000170!4.27e-16!14;UBERON:0005597!4.27e-16!14;UBERON:0000118!4.27e-16!14;UBERON:0005153!3.30e-13!17;UBERON:0005178!3.30e-13!17;UBERON:0005181!3.30e-13!17;UBERON:0002224!3.30e-13!17;UBERON:0000915!3.30e-13!17;UBERON:0008947!3.30e-13!17;UBERON:0003258!3.30e-13!17;UBERON:0000310!2.88e-10!6;UBERON:0001443!2.88e-10!6;UBERON:0005157!3.39e-08!27;UBERON:0000065!5.16e-07!41;UBERON:0001004!7.85e-07!42|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.38298282882125,1.04479915655574,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241177159752417,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0.189491411770485,0,0,0,0.837531287209079,0,0.195133647857799,0.157635144106191,0,0,0.163863314715738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.108005340821801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129920822977795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.188626341386076,0,0,0,0,0.115884325944855,0,0,0,0,0,0,0,0,0,0,0,0.135804113845862,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:57390214..57390221,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=50 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:57390214..57390221,+ | |||
|description=CAGE_peak_at_chr12:57390214..57390221,+ | |||
|id=chr12:57390214..57390221,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000084,5.67e-17,11;CL:0000827,5.67e-17,11;CL:0000838,1.13e-15,12;CL:0000542,1.42e-14,13;CL:0000051,1.42e-14,13;CL:0000738,1.86e-11,17;CL:0002087,1.86e-11,17;CL:0002031,3.41e-08,25 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002048!4.27e-16!14;UBERON:0000117!4.27e-16!14;UBERON:0000171!4.27e-16!14;UBERON:0000170!4.27e-16!14;UBERON:0005597!4.27e-16!14;UBERON:0000118!4.27e-16!14;UBERON:0005153!3.30e-13!17;UBERON:0005178!3.30e-13!17;UBERON:0005181!3.30e-13!17;UBERON:0002224!3.30e-13!17;UBERON:0000915!3.30e-13!17;UBERON:0008947!3.30e-13!17;UBERON:0003258!3.30e-13!17;UBERON:0000310!2.88e-10!6;UBERON:0001443!2.88e-10!6;UBERON:0005157!3.39e-08!27;UBERON:0000065!5.16e-07!41;UBERON:0001004!7.85e-07!42 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.38298282882125,1.04479915655574,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241177159752417,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0.189491411770485,0,0,0,0.837531287209079,0,0.195133647857799,0.157635144106191,0,0,0.163863314715738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.108005340821801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129920822977795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.188626341386076,0,0,0,0,0.115884325944855,0,0,0,0,0,0,0,0,0,0,0,0.135804113845862,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:57390214..57390221,+ | |||
}} |
Latest revision as of 03:05, 5 August 2015
Short description: | p@chr12:57390214..57390221, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:57390214..57390221, + |
Coexpression cluster: | MCL_coexpression_mm9:50 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
T cell | 5.67e-17 | 11 |
pro-T cell | 5.67e-17 | 11 |
lymphoid lineage restricted progenitor cell | 1.13e-15 | 12 |
lymphocyte | 1.42e-14 | 13 |
common lymphoid progenitor | 1.42e-14 | 13 |
leukocyte | 1.86e-11 | 17 |
nongranular leukocyte | 1.86e-11 | 17 |
hematopoietic lineage restricted progenitor cell | 3.41e-08 | 25 |